收费全文 | 2532篇 |
免费 | 158篇 |
国内免费 | 13篇 |
耳鼻咽喉 | 32篇 |
儿科学 | 79篇 |
妇产科学 | 41篇 |
基础医学 | 349篇 |
口腔科学 | 36篇 |
临床医学 | 224篇 |
内科学 | 608篇 |
皮肤病学 | 46篇 |
神经病学 | 306篇 |
特种医学 | 33篇 |
外科学 | 322篇 |
综合类 | 7篇 |
一般理论 | 1篇 |
预防医学 | 346篇 |
眼科学 | 27篇 |
药学 | 165篇 |
中国医学 | 9篇 |
肿瘤学 | 72篇 |
2023年 | 7篇 |
2022年 | 19篇 |
2021年 | 54篇 |
2020年 | 26篇 |
2019年 | 69篇 |
2018年 | 53篇 |
2017年 | 48篇 |
2016年 | 35篇 |
2015年 | 53篇 |
2014年 | 86篇 |
2013年 | 112篇 |
2012年 | 173篇 |
2011年 | 173篇 |
2010年 | 101篇 |
2009年 | 113篇 |
2008年 | 144篇 |
2007年 | 168篇 |
2006年 | 137篇 |
2005年 | 129篇 |
2004年 | 147篇 |
2003年 | 129篇 |
2002年 | 138篇 |
2001年 | 71篇 |
2000年 | 88篇 |
1999年 | 79篇 |
1998年 | 27篇 |
1997年 | 25篇 |
1996年 | 21篇 |
1995年 | 20篇 |
1994年 | 12篇 |
1993年 | 9篇 |
1992年 | 27篇 |
1991年 | 18篇 |
1990年 | 25篇 |
1989年 | 24篇 |
1988年 | 17篇 |
1987年 | 14篇 |
1986年 | 14篇 |
1985年 | 8篇 |
1984年 | 19篇 |
1983年 | 4篇 |
1982年 | 7篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 6篇 |
1976年 | 10篇 |
1974年 | 5篇 |
1973年 | 5篇 |
Background
The recent introduction of biological anticancer therapy has renewed the interest in functional imaging of tumor-associated angiogenesis (TAA) as a tool to monitor early therapy response. The present study evaluated imaging of TAA using P1227, a novel, small molecular magnetic resonance imaging (MRI) probe targeting αvβ3 integrin.Methods
HT29 human colorectal cancers were grown in athymic mice. Dynamic MRI was performed using a three-dimensional VIBE sequence up to 110 min after injection of P1227 or gadolinium–tetraazacyclododecane tetraacetic acid (Gd–DOTA). Specificity was assessed by using P1227 1 h after intravenous administration of the αvβ3 inhibitor cilengitide. Regions of interest were drawn encompassing the tumor rim and normal muscle. Imaging data were compared with microvessel density and αvβ3 expression.Results
Using P1227, specific enhancement of the angiogenic tumor rim, but not of normal muscle, was observed, whereas Gd–DOTA enhanced tumor and normal muscle. After administering cilengitide, enhancement with P1227, but not with DOTA, was significantly suppressed during the first 20 min. When using P1227, a significant correlation was observed between normalized enhancement of the tumor rim and immunohistochemical αvβ3 integrin expression.Conclusions
Molecular MRI using a small monogadolinated tracer targeting αvβ3 integrin and moderate magnetic field strength holds promise in assessing colorectal TAA. 相似文献Objectives
To assess 1) the association of lipid oxidation biomarkers with 10-year coronary artery disease (CAD) events and subclinical atherosclerosis, and 2) the reclassification capacity of these biomarkers over Framingham-derived CAD risk functions, in a general population.Methods
Within the framework of the REGICOR study, 4782 individuals aged between 25 and 74 years were recruited in a population-based cohort study. Follow-up of the 4042 who met the eligibility criteria was carried out. Plasma, circulating oxidized low-density lipoprotein (oxLDL) and oxLDL antibodies (OLAB) were measured in a random sample of 2793 participants.End-points included fatal and non-fatal acute myocardial infarction (AMI) and angina. Carotid intima-media thickness (IMT) in the highest quintile and ankle-brachial index <0.9 were considered indicators of subclinical atherosclerosis.Results
Mean age was 50.0 (13.4) years, and 52.4% were women. There were 103 CAD events (34 myocardial infarction, 43 angina, 26 coronary deaths), and 306 subclinical atherosclerosis cases. Oxidized LDL was independently associated with higher incidence of CAD events (HR = 1.70; 95% Confidence Interval: 1.02–2.84), but not with subclinical atherosclerosis. The net classification index of the Framingham-derived CAD risk function was significantly improved when ox-LDL was included (NRI = 14.67% [4.90; 24.45], P = 0.003). No associations were found between OLAB and clinical or subclinical events. The reference values for oxLDL and OLAB are also provided (percentiles).Conclusions
OxLDL was independently associated with 10-year CAD events but not subclinical atherosclerosis in a general population, and improved the reclassification capacity of Framingham-derived CAD risk functions. 相似文献This study aimed to investigate whether patients with chronic obstructive pulmonary disease (COPD) presenting asthma overlap (ACO) benefit similarly in comparison to patients with only COPD after a 12-week high-intensity exercise training (ET) program.
MethodsSubjects with a diagnosis of COPD alone or ACO were evaluated and compared before and after a high-intensity ET program composed of walking and cycling plus strengthening exercises of the upper and lower limbs (3 days/week, 3 months, 36 sessions). Assessments included spirometry, bioelectrical impedance, 6-min walk test (6MWT), London Chest Activity of Daily Living Scale (LCADL), Hospital anxiety and depression Scale, modified Medical Research Council Scale (mMRC), Saint George Respiratory Questionnaire (SGRQ), and respiratory and peripheral muscle strength [manovacuometry and 1-repetition maximum test (quadriceps femoris, biceps and triceps brachialis), respectively]. ACO was defined according to Sin et al. (Eur Respir J 48(3):664-673, 2016).
ResultsThe sample was composed of 74 subjects (57% male, age 67 ± 8 years, BMI 26 (21–32) kg/m2, FEV1 47 ± 17%predicted), and 12 (16%) of them were classified as presenting ACO. Both groups improved pulmonary function, 6MWT, peripheral and inspiratory muscle strength, LCADL, and SGRQ after ET (p < 0.005 for all). There were no significant interactions between ACO and COPD on ET effects (p > 0.05 for all). Likewise, there was no difference in the proportion of patients achieving the minimum clinical important difference for 6MWT and mMRC.
ConclusionHigh-intensity exercise training generates similar benefits in patients with COPD regardless of whether presenting asthma overlap or not.
相似文献